Analyst picks & changes

BioChem Pharma Inc.

SoundView Financial analyst Reijer Lenstra initiated coverage of BioChem Pharma Inc. with a "buy" and a one year price target of $16. Stock of the Canadian company is underfollowed,

Read the full 318 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE